Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genotype 3 Hepatitis C Virus”

Showing 7 of 0 results

Large-scale testing (Phase 3)Study completedNCT01466192
What this trial is testing

Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Relapser Genotype 2 Hepatitis C Infected Patients

Who this might be right for
Chronic Hepatitis C
Tanabe Pharma Corporation 108
Large-scale testing (Phase 3)Study completedNCT01701401
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination (FDC) With and Without Ribavirin for the Treatment of HCV

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 870
Large-scale testing (Phase 3)Study completedNCT00147784
What this trial is testing

HEPMET-1: Evaluate the Feasibility, Mental Sideeffects and the Efficacy of Hepatitis C Treatment in a MMT Group.

Who this might be right for
Opiate DependenceHepatitis
Sorlandet Hospital HF 10
Post-approval studies (Phase 4)Study completedNCT01841775
What this trial is testing

Interferon α 2b Pharmacovigilance Study

Who this might be right for
Hepatitis C, Chronic
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 85
Large-scale testing (Phase 3)Study completedNCT01573351
What this trial is testing

Phase III Hallmark QUAD: ASV+DCV+Peg+Rib (Nulls/Partials)

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb 398
Large-scale testing (Phase 3)Study completedNCT00402428
What this trial is testing

Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients

Who this might be right for
Chronic Hepatitis C
Human Genome Sciences Inc. 1,331
Large-scale testing (Phase 3)Study completedNCT01718145
What this trial is testing

A Phase 3, Comparative Study of Asunaprevir and Daclatasvir Combination Therapy Versus Telaprevir Therapy in Japanese HCV Subjects

Who this might be right for
Hepatitis C Virus Infection
Bristol-Myers Squibb 258

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation